As of September 27, 2019 that stats are as follows:
- ~805 lung injury cases reported across 46 states and 1 US territory.
- 12 deaths confirmed in 10 states
- 69% of patients are male
- nearly 2/3 of patients are 18-34 years old, with 22% between 18-21 and 16% under 18 years old
- All reported patients have a history of e-cigarette product use or vaping
- The latest findings show vaping products which contain THC plays a role in the outbreak
- CDC obtained data from 514 patients on use 30 days prior to symptom onset: 77% used THC containing products; 36% used THC and only THC products; 57% used nicotine-containing products; 16% used nicotine and only nicotine-containing products
The unknown, currently, is the exact or specific chemical exposure(s) causing the lung injuries associated with e-cigarette product use or vaping. No single product or substance has been linked to all injury cases and more information is needed to know whether one or more e-cigarette or vaping products, substances or brand is responsible for the outbreak.
The CDC recommends that all consumers refrain from using all e-cigarette, or vaping products, particularly those containing THC. If you are an adult who used e-cigarettes containing nicotine to quit cigarette smoking, do not return to smoking cigarettes. If you have recently used an e-cigarette or vaping product and you have symptoms like those reported in this outbreak, see a healthcare provider immediately.
Symptoms of Lung Injury reported by Some Patients in This Outbreak:
- Shortness of breath
- chest pain
- abdominal pain
Patients have reported that their symptoms developed over a few days, while others have reported that their symptoms developed over several weeks. A lung infection does not appear to be causing the symptoms.
Monsanto is the company behind the herbicide known as “RoundUp“. The weed and grass killer is known to contain glyphosate, which is believed to be a carcinogen in humans. The EPA, or Environmental Protection Agency, estimates that over 100 million pounds of the herbicide are used annually in the United States.
Germany based, Bayer AG, acquired Monsanto in June of 2018, along with the over 13,000 lawsuits in baggage.
The majority of plaintiffs used Roundup on a regular basis. It was used weekly, monthly, or even daily, over several years. In some instances, the product was even spilled on the person’s body.
Update: Sandoz Inc. Joins recall of its ranitidine products in the 150mg and 300mg capsules, see product list below.
The heartburn or acid reflux aid, ranitidine, in 75 mg and 150 mg made by Apotex, is being recalled due to the potential for detection of an amount of unexpected impurity, N-nitrosodimethylamine (NDMA). It is noted that the affected Ranitidine Hydrochloride Tablets were distributed nationwide
Apotex Corp. is voluntarily, on a precautionary basis, recalling Ranitidine Tablets 75mg and 150mg (All pack sizes and Formats) to the Retail level. Apotex has learned from the U.S. Food and Drug Administration and other Global regulators that some ranitidine medicines including brand and generic formulations of ranitidine regardless of the manufacturer, contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA) at low levels. To date, Apotex has not received any reports of adverse events related to use of the product.
NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests. NDMA is a known environmental contaminant and found in water and foods, including meats, dairy products, and vegetables.
Ranitidine Hydrochloride Tablet is an over the counter (OTC) oral product indicated for the relief of heartburn associated with acid indigestion and sour stomach and prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain foods and beverages. The affected Ranitidine Hydrochloride Tablets can be identified by NDC numbers stated on the product label.
|Product||Strength||Pack Size||NDC Number|
|Ranitidine tablets, USP 150mg- acid reducer (Rite Aid)||150 mg||50’s Bottle||11822-6052-1|
|Ranitidine tablets, USP 150mg- acid reducer (Rite Aid)||150 mg||65’s Bottle||11822-6052-2|
|Ranitidine tablets, USP 150mg- acid reducer (Rite Aid)||150 mg||95’s Bottle||11822-4727-3|
|Ranitidine tablets, USP 150mg- acid reducer (Walmart)||150 mg||65’s Bottle||49035-117-06|
|Ranitidine tablets, USP 150mg- acid reducer (Walmart)||150 mg||24’s Bottle||49035-100-00|
|Wal-Zan® 150 RANITIDINE TABLETS, USP 150 mg / ACID REDUCER (WALGREENS)||150 mg||200’s Bottle||0363-1030-07|
|Product||Strength||Pack Size||NDC Number|
|Ranitidine tablets, USP 150 mg – acid reducer (Rite Aid)||150 mg||24’s Bottle||11822-6051-8|
|Ranitidine tablets, USP 150mg- acid reducer (Walmart)||150 mg||130’s Bottle||49035-100-07|
|Wal-Zan® 150 RANITIDINE TABLETS, USP 150 mg / ACID REDUCER (WALGREENS)||150 mg||24’s Bottle||0363-1013-02|
|Wal-Zan® 75 RANITIDINE TABLETS, USP 75 mg / ACID REDUCER (WALGREENS)||75 mg||30’s Bottle||0363-1029-03|
|Cool mint Ranitidine tablets, USP 150 mg – acid reducer (Rite Aid)||150 mg||24’s Bottle||11822-6107-4|
|Wal-Zan® 150 RANITIDINE TABLETS, USP 150 mg / ACID REDUCER (WALGREENS)||150 mg||65’s Bottle||0363-1030-06|
|Wal-Zan® 150 RANITIDINE TABLETS, USP 150 mg / ACID REDUCER (WALGREENS)||150 mg||95’s Bottle||0363-1030-09|
Sandoz Inc. list:
|Product Name||NDC Number||Lot Nbr.||Expiration Date||Date of Manufacture|
|RANITIDINE 150mg Capsules 500 count||0781-2855-05||HD1862||4/30/2020||4/19/2017|
|RANITIDINE 150mg Capsules 500 count||0781-2855-05||HP9438||9/30/2020||9/5/2017|
|RANITIDINE 150mg Capsules 500 count||0781-2855-05||HP9439||9/30/2020||9/6/2017|
|RANITIDINE 150mg Capsules 500 count||0781-2855-05||HP9440||9/30/2020||9/5/2017|
|RANITIDINE 150mg Capsules 60 count||0781-2855-60||HC9266||4/30/2020||4/19/2017|
|RANITIDINE 150mg Capsules 60 count||0781-2855-60||HD1865||4/30/2020||4/19/2017|
|RANITIDINE 150mg Capsules 60 count||0781-2855-60||HP9441||9/30/2020||9/6/2017|
|RANITIDINE 150mg Capsules 60 count||0781-2855-60||JK7994||8/31/2021||8/7/2018|
|RANITIDINE 150mg Capsules 60 count||0781-2855-60||JK8659||8/31/2021||8/7/2018|
|RANITIDINE 300mg Capsules 30 count||0781-2865-31||HD8625||4/30/2020||4/27/2017|
|RANITIDINE 300mg Capsules 30 count||0781-2865-31||HD9275||4/30/2020||4/27/2017|
|RANITIDINE 300mg Capsules 30 count||0781-2865-31||HU2207||8/31/2020||8/24/2017|
|RANITIDINE 300mg Capsules 30 count||0781-2865-31||HX6676||3/31/2021||3/20/2018|
|RANITIDINE 300mg Capsules 30 count||0781-2865-31||HX6677||3/31/2021||3/20/2018|
Fisher Price is recalling their inclined sleeper accessory included with all models of Fisher-Price Ultra-Lite Day & Night Play Yards due to reports of infant fatalities being reported from use of other inclined sleep products, after the infants rolled from their back to their stomach or side while unrestrained, or under other circumstances. Approximately 71,000 units are being recalled.
Salmonella is an organism that can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea, nausea, vomiting and abdominal pain.
Grande Produce has announced a voluntary recall of a limited quantity of Papaya Maradol (with the brand name Caribeña labeled on cartons) distributed during the dates of July 10 and July 19 due to a potential health risk from Salmonella.
According to Grande Produce, a Maryland distribution center where the papayas were delivered has already notified retail customers to remove the recalled papayas from inventories, store shelves and the stream of commerce. Recall effectiveness checks are already underway by Grande Produce.
The only papayas subject to the recall carry a “Caribeña” brand label on cartons and were shipped during the dates of July 10 to July 19. No other papayas or fresh produce distributed by Grande Produce are subject to the recall.
Grande Produce has ceased importation of papayas from the grower and is taking all precautionary measures to ensure the safety of its imported produce. The company is also coordinating closely with the U.S. Food and Drug Administration and other regulatory agencies in their investigations and will provide any assistance possible.
Environmental microbial testing conducted by Grande Produce of its facilities has been negative for the Salmonella organism to-date. Specific sources of what health officials now believe maybe two separate Salmonella outbreaks have not yet been determined. Of the 47 cases reported nationally, five illnesses are currently reported in the State of Maryland where Grande Produce distributed product.